effects of semaglutide on chronic kidney disease Long-term outcomes in obesity and cardiovascular in the SELECT trial The Effects of Semaglutide on

Side effects are usually mild to moderate, and in the clinical trials more than 90% of those treated with semaglutide / Wegovy and tirzepatide / Zepbound were able to stay on the medications

Dried fruit

A 2021 study included over 1300 participants, each given a weekly subcutaneous injection of 2.4 mg of semaglutide in addition to lifestyle modifications

While specific requirements can vary by provider, clients are commonly considered good candidates if they meet one of the following criteria: A BMI of 30 or higher (classified as obesity) A BMI of 27 or higher with at least one weight-related health condition, such as high blood pressure, high cholesterol, type 2 diabetes, prediabetes, or sleep apnea In addition, candidates should be in overall stable health, not pregnant or breastfeeding, and not have a personal or family history of certain medical conditions such as medullary thyroid carcinoma or MEN2 (Multiple Endocrine Neoplasia type 2)